Kazakhstan Approves $71 Million Biopharmaceutical Plant in Almaty Region

The Astana Times provides news and information from Kazakhstan and around the world. ALMATY – Kazakh government has approved the construction of a 32.5 billion tenge (US$71 million) full-cycle biopharmaceutical plant in the Alatau Special Economic Zone as part of broader efforts to expand domestic pharmaceutical production and reduce reliance on imports. The investment agreement between Kazakhstan’s Health Ministry and Steppe Pharmaceuticals was approved by Prime Minister Olzhas… The post Kazakhstan Approves $71 Million Biopharmaceutical Plant in Almaty Region appeared first on The Astana Times.